Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

NIO's struggles with scale, cash burn, and competition make its future uncertain. Learn why NIO stock carries significant ...

The new boss at Aston lays out the groundwork for the next few years of the British brand.

More stable investment management and net interest income could cause investors to reassess Goldman's earnings quality and increase their willingness to pay a premium for it.

The dual degree program in Mathematics and Industrial Engineering at Gallaudet University and Rochester Institute of ...

Morgan Stanley has built a more stable business model, and its shift to wealth management from investment banking will continue to be a main part of the company’s story over the long term. Investment ...

This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...

Operator Good morning, and welcome to S&P Global's fourth quarter and full year 2024 earnings conference call. I'd like to ...

Q2 2025 Earnings Call Transcript February 4, 2025 Premier, Inc. misses on earnings expectations. Reported EPS is $0.25 EPS, ...

If derivatives are desired (e.g. for stochastic gradient descent), Enoki performs transparent forward or reverse-mode automatic differentiation of the entire program. Finally, Enoki can do all of the ...

Methods A biomimetic human periosteum-derived cell (hPDC) model of osteogenic differentiation was used in combination ... and license their derivative works on different terms, provided the original ...